Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-01
1998-09-15
Elliott, George C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435325, 536 245, A61K 3170, C12N 506, C07H 2100
Patent
active
058078371
ABSTRACT:
A composition and method of treatment or prophylaxis of a viral infection in a mammal, such as a human, are provided. The compounds in the composition and which are administered in the method, are oligodeoxyribonucleic acid derivatives of the formula (1): ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are hydrogen atoms, alkyl groups, aryl groups, and anthraquinonyl groups; Z is carbon or silicon; or R.sub.2, R.sub.3 and Z together represent fluorenyl or xanthenyl; R.sub.4 is a hydrogen atom, an alkyl group or an aryl group; Y.sub.1, Y.sub.3 and Y.sub.4 are oxygen, sulfur or >NH; Y.sub.2 is oxygen, sulfur, >NH, alkylene or phenylene; X is an alkylene group; m and n are each 0 to 10; and B is an oligodeoxyribonucleotide of a chain length of 3 to 9, or salts thereof.
REFERENCES:
patent: 4904582 (1990-02-01), Tullis
patent: 5220003 (1993-06-01), Jung et al.
patent: 5674856 (1997-10-01), Furukawa et al.
Bergstrom et al, "Organoiron mediated alkylation of phosphite esters: Synthesis of (Dicarbonyl)(n5-cyclopentadienyl)iron-derived nucleoside phosphonate esters", J. Org. Chem. 57:873-876, 1992.
Mitchell et al, "Boron trifluoride-methanol complex as a nondepurinating detritylating agent in DNA synthesis", Nucleic Acids Res. 18(17) 5321 (Abstract Only), 1990.
Caruthers, "Synthesis of oligonucleotides and oligonucleotide analogues" in (Antisense inhibitors of Gene Expression, pp. 7-24, J.S. Cohen ed., CRC press, Boca Raton, FL), 1989.
Niedlein et al, "Synthesen und Untersuchungen von klasse von heterocyclen", Helv. Chim. Acta 76:2407-2417, 1993.
Renault et al, "Synthesis and antiviral evaluation of furopyrimidine diones cyclic and acyclic, nucleoside analogues", Heterocycles 41(5):937-945, 1995.
Jois et al, "Synthesis and antiviral evaluation of some novel Chem. 30:1289-1292, 1993.
Verheggen et al, "Synthesis and antiherpes virus activity of 1,5 anhydrohexitol nucleosides", J. Med. Chem. 36:2033-2040, 1993.
Taunton-Rigby et al, "Oligonucleotide synthesis:II. The use of substituted trityl groups", J. Org. Chem. 37(7):956-964, 1972.
Gura "Antisense has growing pains" Science 270:575-577, Oct. 1995.
Johnston et al. "Present status and future prospects for HIV Therapies" Science 260: 1286-1293, May 1995.
Whitton "Antisense treatment of viral infection" Adv. Virus Res. 44: 267-303, 1994.
Chemical Abstracts, vol. 98, No. 11, 1983, abstract No. 89801f, N. Balgobin et al, "An Efficient Chemical Synthesis of a Biololgically Functional DNA Molecule . . . ", p. 599.
Chemical Abstracts, vol. 98, No. 11, 1983, abstract No. 89808p, N. Balgobin et al, "A Novel Strategy for the Chemical Synthesis of DNA and RNA Fragments using 2-Oxymethyleneanthraquinone (MAQ) as a 3'-Terminal Phosphate Protecting Group", p. 599.
Chemical Abstracts, vol. 97, No. 21, 1982, abstract No. 182794v, C. Gioeli et al, "Fluorene-9-methyl-, a Phosphate Protecting Group: its Application in the Phosphotriester Approach through the Synthesis of Tetracsathymidylic Acid", p. 868.
Journal Of The Chemical Society, Chemical Communications, vol. 12, 1982, pp. 672-674, C. Gioeli et al, "The Fluoren-9-ylmethoxycarbonyl Group for the Protection of Hydroxy Groups: Its Application in the Synthesis of an Octathymidylic Acid Fragment".
Chemical Abstracts, vol. 119, No. 21, 1993, abstract No. 226347f, R. Ishido et al, "2-(2-(monomethoxytrityloxy)ethylthio)ethyl Group and its use as a Protecting Group for Phosphoric Acid Residue in Oligonucleotide Synthesis", p. 1059; of JP-A-O 532 614.
Tetrahedron Letters, vol. 27, No. 39, 1986, T. Horn et al., "A Chemical 5'-Phosphorylation of Oligodeoxyribonucleotides that can be Monitored by trityl Cation Release", pp. 4705 to 4708.
Paul C. Zamecnik et al, "Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide", Proc. Natl. Acad. Sci. USA, vol. 75, No. 1, pp. 280-284 (1978).
Paul C. Zamecnik et al, "Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA", Proc. Natl. Acad. Sci. USA, vol. 83, pp. 4143-4146 (1986).
Woolf, Its not the size, it's the potency. Nature Biotechnology 14: 824, Jul. 1996.
Furukawa Hidehiko
Hotoda Hitoshi
Kaneko Masakatsu
Koizumi Makoto
Momota Kenji
Elliott George C.
Larsen Thomas G.
Sankyo Company Limited
LandOfFree
Composition and method for the treatment or prophylaxis of viral does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for the treatment or prophylaxis of viral, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for the treatment or prophylaxis of viral will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-87284